Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiphospholipids and pregnancy--a review

C Yap1, S C Yeoh, O A Viegas

  • 1Department of Obstetrics & Gynaecology, Singapore General Hospital, Singapore.

Singapore Medical Journal
|January 14, 1999
PubMed
Summary

Antiphospholipid antibodies cause a syndrome of blood clots and pregnancy loss. Treatment involves aspirin, heparin, and corticosteroids for this autoimmune condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DOSET: dose optimization with simultaneous efficacy and toxicity evaluation, motivated by a first-in-human phase I CAR T lymphoma trial.

ESMO open·2026
Same author

No One Left Behind: The Design of Young Biomedical Science Programme (YBMS) on Medical Education for Postdoctoral Fellows.

Medical science educator·2025
Same author

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

U-PRO-CRM: designing patient-centred dose-finding trials with patient-reported outcomes.

ESMO open·2024
Same author

Accrual and statistical power failure in published adjuvant phase III oncology trials: a comprehensive analysis from 2013 to 2023.

ESMO open·2024
Same author

The Utility of Sirolimus Eluting Balloons in the Setting of Chronic Limb Threatening Ischaemia in Asian Patients from Singapore - 12 Months Results of the PRISTINE Registry.

Cardiovascular and interventional radiology·2024

Area of Science:

  • Immunology
  • Hematology
  • Obstetrics & Gynecology

Background:

  • Antiphospholipid antibodies are linked to a syndrome involving low platelets, blood clots, and pregnancy loss.
  • The exact cause of this autoimmune response remains unclear.
  • This condition results in abnormal platelet aggregation and thrombosis.

Purpose of the Study:

  • To summarize the clinical characteristics and management of antiphospholipid antibody syndrome.

Main Methods:

  • Review of existing literature on antiphospholipid antibody syndrome.
  • Description of clinical manifestations including thrombocytopenia, thrombosis, and fetal loss.
  • Outline of standard treatment protocols.

Main Results:

  • The syndrome is characterized by recurrent arterial and venous thromboses.
  • Recurrent fetal loss is a significant clinical feature.
  • Thrombocytopenia is commonly observed in affected individuals.

Conclusions:

  • Antiphospholipid antibody syndrome is an autoimmune disorder with serious thrombotic and obstetric complications.
  • Current management focuses on anticoagulation and antiplatelet therapy.
  • Low-dose aspirin, heparin, and corticosteroids are the primary treatments.

Related Experiment Videos